US market experiences slight softening as the top four trauma players all post sequential declines in Q218
Among the many topics covered Q218 Trauma Market Recap are:
- Top Players Post Slight Sequential Downturns
- New Players Experience Delays
- IM Nailing Soars Due to Existing Products along with New Intros
- Trauma Regulatory Highlights
The top four trauma players all posted slight sequential declines in Q218. DePuy Synthes cited pricing pressure, while Smith & Nephew attributed their downturn to a 2017 Middle East tender order, indicating...
Read entire Q218 US Trauma Market Recap including news, data and analysis*...
*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
Request SmartTRAK Subscription Info